Ralliant (NYSE:RAL) Lowered to “Buy” Rating by Wall Street Zen

Wall Street Zen lowered shares of Ralliant (NYSE:RAL) from a strong-buy rating to a buy rating in a research note published on Sunday morning.

Several other research firms have also commented on RAL. Vertical Research lowered shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective on the stock. in a research note on Wednesday, May 27th. Oppenheimer raised their target price on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Evercore began coverage on Ralliant in a research report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target on the stock. Finally, Truist Financial restated a “buy” rating and issued a $82.00 price target (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Stock Performance

Shares of RAL stock opened at $61.65 on Friday. Ralliant has a 12 month low of $37.27 and a 12 month high of $75.41. The stock has a market cap of $6.82 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 2.29 and a beta of 1.61. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. The company’s fifty day moving average price is $68.40 and its 200-day moving average price is $56.53.

Ralliant (NYSE:RAL) last released its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, equities analysts expect that Ralliant will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is presently -1.84%.

Insider Activity

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the transaction, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the transaction, the senior vice president owned 31,668 shares in the company, valued at approximately $2,280,096. This represents a 16.07% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company’s stock.

Institutional Investors Weigh In On Ralliant

Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. bought a new position in Ralliant in the 2nd quarter valued at approximately $1,039,481,000. Dodge & Cox increased its holdings in shares of Ralliant by 13.3% in the 4th quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after purchasing an additional 1,434,376 shares in the last quarter. California State Teachers Retirement System increased its holdings in shares of Ralliant by 7,051.8% in the 2nd quarter. California State Teachers Retirement System now owns 9,356,090 shares of the company’s stock worth $688,889,000 after purchasing an additional 9,225,268 shares in the last quarter. Viking Global Investors LP purchased a new position in shares of Ralliant in the second quarter worth $257,200,000. Finally, Millennium Management LLC raised its stake in shares of Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares during the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.